Search

Displaying results 8291 - 8300 of 9314 in total
  1. Drug

    Emicerfont

    go.drugbank.com/drugs/DB12910
    Investigational

    Emicerfont has been used in trials studying the diagnostic and treatment of Social Anxiety Disorder and Irritable Bowel Syndrome (IBS).

  2. Drug

    Rosiptor

    go.drugbank.com/drugs/DB13012
    Investigational

    AQX-1125 has been used in trials studying the treatment of COPD, Atopic Dermatitis, Interstitial Cystitis, and Bladder Pain Syndrome.

  3. Drug

    1alpha-Hydroxyvitamin D5

    go.drugbank.com/drugs/DB13097
    Investigational

    1alpha-Hydroxyvitamin D5 (CARD-024) has been used in trials studying the treatment of Drug Safety and Heart; Disease, Activity.

  4. Drug

    Erteberel

    go.drugbank.com/drugs/DB07933
    Investigational

    Erteberel is an estrogen receptor beta agonist that has been used in trials studying the treatment of Benign Prostatic Hyperplasia.

  5. Drug

    Amber

    go.drugbank.com/drugs/DB14326
    Investigational

    Amber is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  6. Drug

    Mangostin

    go.drugbank.com/drugs/DB14371
    Investigational

    Mangostin is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  7. Drug

    Pumice

    go.drugbank.com/drugs/DB14374
    Investigational

    Pumice is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  8. Drug

    Profoxydim

    go.drugbank.com/drugs/DB14820
    Experimental

    Profoxydim is under investigation in clinical trial NCT02728011 (Pilot Trial Comparing Computerised Cognitive Exercises to Tetris in Adolescents With ADHD).

  9. Drug

    Coleneuramide

    go.drugbank.com/drugs/DB14932
    Investigational

    Coleneuramide is under investigation in clinical trial NCT00307749 (Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy).

  10. Drug

    Dianexin

    go.drugbank.com/drugs/DB15000
    Investigational

    Dianexin is under investigation in clinical trial NCT00615966 (Phase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients).